Dowling & Yahnke LLC Buys 818 Shares of Express Scripts Holding Co (ESRX)

Dowling & Yahnke LLC raised its stake in shares of Express Scripts Holding Co (NASDAQ:ESRX) by 3.1% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 27,134 shares of the company’s stock after purchasing an additional 818 shares during the quarter. Dowling & Yahnke LLC’s holdings in Express Scripts were worth $2,578,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Oregon Public Employees Retirement Fund raised its stake in shares of Express Scripts by 0.7% in the third quarter. Oregon Public Employees Retirement Fund now owns 230,533 shares of the company’s stock valued at $21,903,000 after acquiring an additional 1,690 shares during the last quarter. Nissay Asset Management Corp Japan ADV raised its stake in shares of Express Scripts by 1.2% in the third quarter. Nissay Asset Management Corp Japan ADV now owns 79,583 shares of the company’s stock valued at $7,561,000 after acquiring an additional 957 shares during the last quarter. Court Place Advisors LLC bought a new position in shares of Express Scripts in the third quarter valued at approximately $207,000. Assenagon Asset Management S.A. raised its stake in shares of Express Scripts by 4.4% in the third quarter. Assenagon Asset Management S.A. now owns 33,101 shares of the company’s stock valued at $3,145,000 after acquiring an additional 1,393 shares during the last quarter. Finally, NN Investment Partners Holdings N.V. raised its stake in shares of Express Scripts by 8.5% in the third quarter. NN Investment Partners Holdings N.V. now owns 163,174 shares of the company’s stock valued at $15,504,000 after acquiring an additional 12,745 shares during the last quarter. 84.74% of the stock is currently owned by institutional investors.

ESRX stock opened at $95.42 on Wednesday. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.71 and a quick ratio of 0.59. Express Scripts Holding Co has a fifty-two week low of $59.17 and a fifty-two week high of $97.22. The company has a market capitalization of $53.00 billion, a P/E ratio of 13.44, a P/E/G ratio of 1.20 and a beta of 1.01.

Express Scripts (NASDAQ:ESRX) last posted its quarterly earnings data on Wednesday, August 1st. The company reported $2.22 earnings per share for the quarter, topping the consensus estimate of $2.20 by $0.02. Express Scripts had a net margin of 4.65% and a return on equity of 25.49%. The firm had revenue of $25.64 billion during the quarter, compared to analysts’ expectations of $25.43 billion. During the same quarter in the previous year, the company posted $1.73 EPS. Express Scripts’s revenue was up 1.2% on a year-over-year basis. As a group, sell-side analysts forecast that Express Scripts Holding Co will post 9.07 EPS for the current fiscal year.

In related news, insider Christine Houston sold 12,898 shares of the business’s stock in a transaction that occurred on Friday, August 10th. The shares were sold at an average price of $85.00, for a total value of $1,096,330.00. Following the completion of the transaction, the insider now owns 110,908 shares in the company, valued at approximately $9,427,180. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 0.79% of the company’s stock.

A number of research analysts have recently issued reports on ESRX shares. BidaskClub cut shares of Express Scripts from a “buy” rating to a “hold” rating in a research note on Tuesday, July 10th. Credit Suisse Group cut shares of Express Scripts from an “outperform” rating to a “neutral” rating and lifted their target price for the company from $90.00 to $96.50 in a research note on Tuesday, September 18th. Royal Bank of Canada lifted their target price on shares of Express Scripts to $94.00 and gave the company an “outperform” rating in a research note on Monday, August 27th. Zacks Investment Research cut shares of Express Scripts from a “hold” rating to a “sell” rating in a research note on Monday, July 23rd. Finally, William Blair upgraded shares of Express Scripts from a “market perform” rating to an “outperform” rating in a research note on Wednesday, August 1st. Two analysts have rated the stock with a sell rating, twelve have issued a hold rating, five have issued a buy rating and one has given a strong buy rating to the company. Express Scripts currently has a consensus rating of “Hold” and an average price target of $86.36.

About Express Scripts

Express Scripts Holding Company operates as a pharmacy benefit management (PBM) company in the United States and Canada. The company's PBM segment offers clinical solutions; and specialized pharmacy care, home delivery and specialty pharmacy, retail network pharmacy administration, benefit design consultation, drug utilization review, drug formulary management, public exchange, administration of group purchasing organization, and digital consumer health and drug information services.

Recommended Story: Growth Stocks

Want to see what other hedge funds are holding ESRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Express Scripts Holding Co (NASDAQ:ESRX).

Institutional Ownership by Quarter for Express Scripts (NASDAQ:ESRX)

Receive News & Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply